Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinzaparin monitoring in pediatric intensive care patients
NL-OMON26406Unknown
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of tinzaparin in thromboembolism, sponsored by Leiden University Medical Center. Primary endpoints: Anti-Xa levels, Time to adequate anti-Xa levels and 1 more. Status: unknown.
02
Drugs
tinzaparin
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NL-OMON26406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26406.